![]() |
Action on Smoking and Health
A National Legal-Action Antismoking Organization Entirely Supported by Tax-Deductible Contributions
|
Tobacco Funded Research Continues to Raise Ethical Questions [03/10-4]
Excerpts from: Tobacco funds raise ethical quandary
By Geoffrey Ziezulewicz MN Daily [03/09/04]
With a Philip Morris USA grant, University researcher Dr. Jordan Holtzman is examining why smokers get heart disease.
Although tobacco industry grants provide only a small fraction of sponsored research dollars at the University, that research has posed an ethical dilemma on numerous fronts throughout academic institutions in the United States.
Officials at different universities expressed concern that taking tobacco money for research goes against the tenets of medicine. It also poses a conflict of interest question, they said, because of fears the companies will try to influence research outcomes in their favor.
Philip Morris USA awarded approximately $257,000 to Holtzman in fiscal year 2001, said Edward Wink, associate vice president of sponsored projects at the University. The funding will end in June.
The University receives $55.6 million in nongovernmental research funding, according to documents Wink provided.
According to University documents, tobacco companies awarded three other grants totaling $21,000 in previous years. The other projects have been completed.
Tobacco companies funding university research is not a new phenomenon, University epidemiology professor Jean Forster said. Tobacco-funded research became an issue at research universities in the early 1990s, she said. Since then, she said, the amount of research funded by tobacco companies has decreased.
The ethical debate was made apparent in December 2003 when media reports indicated The Ohio State University would use a $6 million gift from Lorillard Tobacco Co. to study the effects of pollution and smoking on the heart and lungs.
Robert Crane, a clinical professor of family medicine at The Ohio State University, is on the state of Ohio's tobacco settlement board and disagrees with tobacco companies funding research.
Stan Glantz, co-author of the book "The Cigarette Papers," which documented and chronicled the tobacco industry's actions and internal policies in the last 50 years, said the industry's track record of funding scientific research is spotty.
For years, tobacco companies have funded and used research to say cigarettes aren't harmful or nicotine isn't addictive, Glantz said.
Many anti-smoking nonprofit organizations have rules in place that disqualify researchers from receiving the organization's grant money if they are also working with tobacco money, said Andrea Mowery, marketing and communications director for the Minnesota Partnership for Action Against Tobacco.
The American Cancer Society announced earlier this year that, starting in 2005, it will not fund any research at any institution that also receives funding from a tobacco company.
But organizations such as the partnership and the American Cancer Society might restrict researchers' academic freedom, said John Finnegan, associate dean for academic affairs at the University's School of Public Health.
| Home Web Page | Search This Site | Learn About ASH | Why Join ASH | Comment on This | Email This Page |